EPZ-6438 (Tazemetostat): Selectivity & Specificity
EPZ-6438 (Tazemetostat) is a potent and selective EZH2 inhibitor (IC50 = 0.697 nM).
Jump to:
- EPZ-6438 (Tazemetostat) Mechanism of Action: EZH2 Inhibition in B-Cell Research
- EPZ-6438 (Tazemetostat) Working Concentration | Cell Culture | Treatment
- EPZ-6438 (Tazemetostat) Solubility in DMSO
- EPZ-6438 (Tazemetostat) VS GSK126 | 3-Deazaneplanocin A (DZNep) Hydrochloride
- EPZ-6438 (Tazemetostat) Molecular Weight | Chemical Structure | Stock Solution
- EPZ-6438 (Tazemetostat) IC50 for Cell-based and Cell-free Assays
- EPZ-6438 (Tazemetostat) Sigma (SBR00098)? Try a better option.
- EPZ-6438 (Tazemetostat) MedChemExpress (HY-13803)? Try a better option.
- EPZ-6438 (Tazemetostat) Cayman (16174)? Try a better option.
- EPZ-6438 (Tazemetostat) Tocris (8093)? Try a better option.
- EPZ-6438 (Tazemetostat) TargetMol (T1788)? Try a better option.
- EPZ-6438 (Tazemetostat) SDS｜MSDS